about
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory SarcoidosisOff-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab--a paradoxical effect? A case report.Sarcoidosis and molecular mimicry--important etiopathogenetic aspects: current state and future directions.TNF-α: a treatment target or cause of sarcoidosis?The continuing evolution of targeted therapy for inflammatory skin disease.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Disfiguring annular sarcoidosis improved by adalimumab.
@ast
Disfiguring annular sarcoidosis improved by adalimumab.
@en
Disfiguring annular sarcoidosis improved by adalimumab.
@nl
type
label
Disfiguring annular sarcoidosis improved by adalimumab.
@ast
Disfiguring annular sarcoidosis improved by adalimumab.
@en
Disfiguring annular sarcoidosis improved by adalimumab.
@nl
prefLabel
Disfiguring annular sarcoidosis improved by adalimumab.
@ast
Disfiguring annular sarcoidosis improved by adalimumab.
@en
Disfiguring annular sarcoidosis improved by adalimumab.
@nl
P2093
P2860
P356
P1476
Disfiguring annular sarcoidosis improved by adalimumab.
@en
P2093
A A Navarini
C A Kaiser
G F L Hofbauer
J Kamarashev
L E French
P2860
P304
P356
10.1159/000328796
P577
2011-05-17T00:00:00Z